Drug · DIN 02478544
EZETIMIBE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 11, 2024; first marketed August 14, 2018.
- Drug Identification Number (DIN)
- 02478544
- Company (DIN owner)
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ezetimibe C10AX09
- Class
- Human
- Record last updated
- August 1, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EZETIMIBE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 11, 2024: NOC 33431Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Manufacturers
- July 11, 2018: NOC 21081Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named EZETIMIBE
- DIN 02422549 · Marketed
- DIN 02431300 · Marketed
- DIN 02429659 · Dormant